- Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature. 2012 Academic Article GET IT
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer.
Breast cancer research and treatment.
Times cited: 73
Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study.
Times cited: 154